Talyst Exhibits at the 340B Coalition Summer Meeting - KTVN Channel 2 - Reno Tahoe News Weather, Video -

Talyst Exhibits at the 340B Coalition Summer Meeting

  • Wendy Damonte's Health Watch ReportsMore>>

  • Request Remind Me 2 Kit

    Request a Remind Me 2 Kit

         More >>
  • Ask the Doctor: Northern Nevada HOPES Clinic

    Ask the Doctor: Northern Nevada HOPES Clinic

    Monday, July 28 2014 7:04 PM EDT2014-07-28 23:04:52 GMT
    Sharon Chamberlain is taking your calls about Northern Nevada Hopes. Learn more about this non-profit community health care clinic in tonight’s Ask the Doctor segment.More >>
    Sharon Chamberlain is taking your calls about Northern Nevada Hopes. Learn more about this non-profit community health care clinic in tonight’s Ask the Doctor segment.More >>
  • Officials: Little Risk of Ebola Outbreak in U.S.

    Officials: Little Risk of Ebola Outbreak in U.S.

    Monday, July 28 2014 5:00 PM EDT2014-07-28 21:00:35 GMT
    U.S. health officials are monitoring the Ebola outbreak in Africa but say the risk of the deadly germ spreading to the United States is remote. The Centers for Disease Control on Monday sent a health alert to U.S. doctors about the outbreak.More >>
    U.S. health officials are monitoring the Ebola outbreak in Africa but say the risk of the deadly germ spreading to the United States is remote. The Centers for Disease Control on Monday sent a health alert to U.S. doctors about the outbreak.More >>

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Talyst

KIRKLAND, Wash., July 14, 2014 /PRNewswire/ -- Talyst, a market leader in pharmacy automation and 340B solutions, will be exhibiting at the 2014 340B Coalition Summer Meeting in Washington, DC. The company will be showcasing its 340B software products and services.  

Talyst is the industry leader in 340B splitting solutions, supplying over 400 customers with a variety of software and services. Talyst offers a range of 340B solutions including its latest solution, AutoSplit® Contract Pharmacy and 340B Compliance Services. AutoSplit Contract Pharmacy is an end-to-end service that allows covered entities the ability to capture additional 340B savings from hospital scripts dispensed at retail pharmacies.

Talyst's 340B Compliance Services supports hospitals and health systems prepare for 340B Drug Pricing Program compliance audits. Talyst assesses and selects 340B solutions and tools to develop a complete Audit Program.

"With our 100% record in successful customer audits, we have proven that we fully understand the complex landscape around 340B regulations," said George Puckett, General Manager of Talyst's 340B business unit. "We are also on the forefront in quickly improving our products based upon regulatory changes that can impact our customers. We are ready for whatever the next roll out of regulations may bring."

To learn more about our products and solutions, visit Talyst at booths #12 and #13. For information about the 340B Coalition, please visit http://340bcoalition.org/2014/overview/.

About Talyst
Talyst is a leader in pharmacy automation and engineers the safer pharmacy. Our solutions provide enterprise-wide medication management across your entire health system to offer greater inventory control, enhanced workflow efficiency, and improved patient safety. As of 2014, Talyst has installed automated solutions in more than 700 integrated healthcare systems, acute-care hospitals, long-term care facilities, and correctional institutions. We offer a powerful software platform with a suite of hardware components to meet your enterprise-wide needs. Follow us on Twitter @Talyst_Inc or visit us at www.talyst.com.

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and Sarkes Tarzian, Inc. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service.